Uncertainties about the use of inhaled nitric oxide in preterm infants

Acta Paediatrica, International Journal of Paediatrics, Supplement

Volumn 90, Issue 436, 2001, Pages 15-18

  Mercier, J C ^a  

^a HÔPITAL ROBERT DEBRÉ   (France)

Author keywords

Nitric oxide; Persistent pulmonary hypertension

Indexed keywords

NITRIC OXIDE; SURFACTANT;

ARTICLE; ARTIFICIAL VENTILATION; BRAIN HEMORRHAGE; CHRONIC LUNG DISEASE; CLINICAL TRIAL; COLOR ULTRASOUND FLOWMETRY; DISEASE SEVERITY; DOPPLER FLOWMETER; DRUG EFFECT; DRUG MECHANISM; FETUS CIRCULATION; HIGH FREQUENCY VENTILATION; HUMAN; HYPOXEMIA; LUNG CIRCULATION; NEWBORN MORBIDITY; OXYGENATION; PREMATURITY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RESPIRATORY FAILURE; SURVIVAL; TREATMENT OUTCOME;

ADMINISTRATION, INHALATION; HUMANS; HYPERTENSION, PULMONARY; INFANT, NEWBORN; INFANT, PREMATURE; NITRIC OXIDE; PROBABILITY; RESPIRATORY INSUFFICIENCY; VASODILATOR AGENTS;

EID: 0035052647     PISSN: 08035326     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Pulmonary surfactant therapy
2. Optimizing alveolar expansion prolongs the effectiveness of exogenous surfactant therapy in the adult rabbit
3. Recent developments in the pathophysiology and treatment of PPHN
4. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor
5. Nitric oxide: Physiology, pathophysiology, and pharmacology
6. Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle
7. Role of endothelium-derived relaxing factor during transition of pulmonary circulation at birth
8. Ontogeny of NO activity and response to inhaled NO in the developing ovine pulmonary circulation
9. Failure of postnatal adaptation of the pulmonary circulation after chronic intrauterine pulmonary hypertension in fetal lambs
10. Ligating the ductus arteriosus before birth causes persistent pulmonary hypertension in the newborn lamb
11. Chronic pulmonary hypertension in utero impairs endothelium-dependent vasodilation
12. Chronic pulmonary hypertension impairs endothelial nitric oxide synthase in the ovine fetus
13. Pulmonary endothelial nitric oxide synthase gene expression is decreased in fetal lambs with pulmonary hypertension
14. Disruption of cGMP production in pulmonary arteries isolated from fetal lambs with pulmonary hypertension
15. Chronic pulmonary hypertension increases fetal lung cGMP phosphodiesterase activity
16. Prolonged endothelin A receptor blockade attenuates chronic intrauterine pulmonary hypertension
17. Inhaled nitric oxide as a cause of selective pulmonary vasodilation in pulmonary hypertension
18. Inhaled nitric oxide in persistent pulmonary hypertension of the newborn
19. Low-dose inhalational nitric oxide in persistent pulmonary hypertension of the newborn
20. Inhaled nitric oxide. A selective pulmonary vasodilator reversing pulmonary vasoconstriction
21. Inhaled nitric oxide reverses pulmonary vasoconstriction in the hypoxeic and acidotic newborn lamb
22. Hemodynamic effects of exogenous nitric oxide in ovine transitional pulmonary circulation
23. Inhaled nitric oxide in full-term infants with hypoxic respiratory failure
24. Inhaled nitric oxide and persistent pulmonary hypertension of the newborn
25. Randomized, multicenter trial of inhaled nitric oxide and high-frequency oscillatory ventilation in severe, persistent pulmonary hypertension of the newborn
26. Improved oxygenation in a randomized clinical trial of inhaled nitric oxide for persistent pulmonary hypertension of the newborn
27. Inhaled nitric oxide for the early treatment of persistent pulmonary hypertension of the newborn: A randomized, double-masked, placebo-controlled, dose-response, multicenter study
28. Early compared with delayed inhaled nitric oxide in moderately hypoxaemic neonates with respiratory failure: A randomised controlled trial
29. Inhaled nitric oxide for respiratory failure in preterm infants
30. Inhaled nitric oxide for respiratory failure in infants born at or near term
31. Nitric oxide inhalation in infants with respiratory distress syndrome
32. Changes in oxygenation and pulmonary haemodynamics in preterm infants treated with inhaled nitric oxide
33. Open randomised controlled trial of inhaled nitric oxide and early dexamethasone in high risk preterm infants
34. Response of premature infants with severe respiratory failure to inhaled nitric oxide
35. The outcome of very low birth weight neonates (≤1500 g) rescued by inhaled nitric oxide: Neurodevelopment in early childhood
36. Inhaled nitric oxide in premature neonates with severe hypoxaemic respiratory failure: A randomised controlled trial
37. Inhaled nitric oxide: A premature remedy for chronic lung disease?